Purpose: To reduce publication bias, systematic reviewers are advised to search conference abstracts to identify randomized controlled trials (RCTs) conducted in humans and not published in full. We assessed the information provided by authors to aid identification of RCTs for reviews. 
Introduction
Randomized controlled trials (RCTs) that are used to inform systematic reviews are typically identified through searching electronic databases, such as PubMed, EMBASE, and the Cochrane Central Register of Controlled Clinical Trials. Because only 60% of trials initially reported as conference abstracts are ever published in full [1] , systematic review authors who neglect to search the grey literature, especially conference abstracts, may fail to identify relevant unpublished trials. Further, because of publication bias, the tendency to publish results based on the strength or direction of findings, systematic reviews that focus only on trials reported in full may present a biased representation of existing evidence.
Clinical trial registration was proposed in the 70's and 80's, in part as a mechanism of combating reporting biases [2.3] , and the notion slowly gained ground in the 90's and 2000's [4, 5, 6] , especially following support from the International Committee of Medical Journal Editors (ICMJE) [7] . Today, registration has been resoundingly endorsed by the scientific community [8, 9] , and systematic review authors are examining the potential for making use of register information to complement what is available in the published literature [10] .
With 100 to 200 abstracts describing clinical trials published annually, the Association for Research in Vision and Ophthalmology (ARVO) annual meeting is an important source of reports of RCTs for the Cochrane Eyes and Vision Group (CEVG). We have searched the ARVO meeting books or the ARVO online abstract repository from 1990 forward for reports of RCTs and controlled clinical trials, to contribute to CEVG's specialized database of trial reports. Because clinical trials represent only 2 to 3% of ARVO abstracts published each year, and completing the searches requires about 45 hours per year [11] , we began a project in 2004 with the initial objective of determining whether it is possible to develop a valid and reliable system for author classification of clinical trials. If so, such a system would obviate the need for labor-intensive handsearching. In response to our request, ARVO conference organizers added a definition and check-off box to the 2004 abstract submission form to indicate whether the submitted abstract described a ''human clinical trial''. Our overall study objective was to assess the reliability of information provided by ARVO abstract authors that might be used to aid in identification of relevant abstracts for systematic reviews. We evaluated whether authors correctly classify abstracts describing RCTs as clinical trials, and as an adjunct to this, determined where investigators are registering their RCTs.
Methods

Identification of Randomized Controlled Clinical Trials
We searched the ARVO annual meeting abstract book (in 2004 we searched a CD-ROM; in 2005 through 2009 we searched online at http://www.arvo.org) to identify abstracts describing RCTs and controlled clinical trials for inclusion in the CEVG specialized trial register. For this study, we include only abstracts reporting RCT findings. Abstracts were classified as RCTs if ''individuals (or other units) followed in the trial were assigned prospectively to one of two (or more) alternative forms of health care using random allocation'' [13] . Because the original purpose of our handsearch of the abstracts was to identify RCTs for the CEVG trial register, and reviewing all abstracts for each year is labor intensive, a single individual (RWS) completed the initial handsearch; this was done in the year following each annual meeting. We downloaded and printed a hard copy of each abstract classified as an RCT. 
Author Classification of Abstract as a Trial
Reference Standard
We compared the list of abstracts provided by the meeting organizers with the abstracts that we had previously classified as RCTs. Any abstract on the list that the handsearcher had not classified as an RCT was re-evaluated. If the handsearcher agreed that the report described an RCT, then that abstract was included in the reference standard for that year.
Thus, for each year, there were two groups of studies: Abstracts in the reference standard:
$ Classified as a clinical trial by the author and as an RCT by the handsearcher; $ Not classified as a clinical trial by the author, but classified as an RCT by the handsearcher.
Abstracts not in the reference standard:
$ Classified as a clinical trial by the author, but not classified as an RCT the handsearcher. $ Not classified as a clinical trial by the author, nor classified as an RCT by the handsearcher.
A second handsearcher (PCS) reviewed the classification of 100% of abstracts that were included in the reference standard, i.e., abstracts that were classified by the handsearcher as an RCT. A 10% sample of abstracts classified by the author as a clinical trial, but not as an RCT by the first handsearcher, and a 5% sample of abstracts not classified as a clinical trial by the author nor as an RCT by the handsearcher were reviewed by another handsearcher (KD or AE). Abstracts in question were re-reviewed by the lead author for a decision or by both readers to arrive at consensus.
Characteristics of Trial Registration Information
We classified the type of organization recorded in the trial registration field (trial register, ethics board/institutional review board, regulatory agency, local authority, or other) for conference abstracts presented in 2007, 2008, and 2009. For trials in the reference standard that were reported by the author as registered at ClinicalTrials.gov, we verified the information by entering the trial registration number provided in the ClinicalTrials.gov search webpage [http://ClinicalTrials.gov].
Data Analyses
We entered into an Access database the program number and year of presentation of each abstract describing an RCT that we identified by handsearching the conference books, and imported the program number and year of presentation 
Results
Classification of Abstracts
The Table 1 ). However, the majority of studies that authors identified were of other types of study design rather than RCTs; only 841/2372 (35%; 95% CI, 34-37) abstracts classified as a clinical trial by authors described an RCT. The remaining abstracts described non-randomized controlled clinical trials, uncontrolled clinical trials, studies not involving humans, or trials in which participants were assigned to a treatment group based on some participant characteristic (e.g., severity of disease) (see Table 2 ).
Registration of Clinical Trials
Authors provided trial registration information at abstract submission for 797 abstracts (see Table 3 ). Of these, 678/797 (85%; 95% CI, 83-88) provided a trial register name. Authors of RCTs tended to provide the name of a trial register more often compared with other study designs; 312/336 (93%; 95% CI, 90-96) abstracts describing RCTs included the name of an approved trial register compared with 366/461 (79%; 95% CI, 76-83) abstracts describing non-RCTs (e.g., nonrandomized controlled clinical trials, uncontrolled clinical trials, cohort studies). We Almost all RCT authors who provided a trial register name specified ClinicalTrials.gov (see Table 4 ). When we checked the trial registration number provided by the author for RCTs registered in ClincalTrials.gov, we found a valid number for 95% of RCTs (261/276; 95% CI, 92-97). Invalid numbers included reports that registration was pending (n = 7), or a number that yielded no results upon searching the ClinicalTrials.gov database or was clearly not a valid registration number (n = 8) (e.g., ''0. 
Discussion
We were disappointed that asking authors to identify their abstracts as describing trials is not reliable, since it could have helped to avoid laborious handsearching of conference abstracts required to identify all RCTs for systematic reviews [14] . If we depended solely on author classification of abstracts, we would not have identified a large proportion of trials since authors correctly identified only 75% of RCTs in our reference standard.
One of the reasons for the development of trial registers is to provide information about all initiated trials, including those remaining unpublished. Although registration does inform the public about the existence of trials, most investigations to date have demonstrated that registration details (e.g., study design, protocol and contact information) are less than optimal for inclusion in systematic reviews [10, 15, 16, 17] . Our findings might suggest that a significant proportion -about one third of RCTs Does not include 576 abstracts that were withdrawn and are not included in the analyses. doi:10.1371/journal.pone.0044183.t001 Table 2 . Abstracts identified by author as controlled trial by study design and year of presentation at ARVO. Includes: description of study methods (e.g., methods for measuring outcomes), systematic reviews, theoretical models, studies on correlation between test methods, and studies with historical controls). doi:10.1371/journal.pone.0044183.t002
Self-Classification of Clinical Trial Abstracts PLOS ONE | www.plosone.orgexplanation for why RCT investigators did not register their study is they do not recognize study designs, including those that require registration. For example, a recent study in China found that a high proportion of authors stating in their article that their trial was randomized revealed that they did not fully understand the principles of randomization when queried directly [18] . Our own experience showed that authors of 9/40 ARVO and American Academy of Ophthalmology 1988-89 meeting conference abstracts, who reported use of randomization, responded that assignment to treatment groups was not random when asked directly [19] . Similarly, investigators of other study designs (e.g., non-randomized trial) may not recognize their study design or that it requires registration. Alternatively, authors may have registered their trials, but may not have entered the required trial registration information on the abstract submission form. Lack of compliance with abstract submission requirements related to trial registration would not be surprising, as compliance with required trial registration is also problematic for journal articles [20, 21] . If including trial registration information is to be meaningful, it should be accurate and complete. Journal editors and conference organizers may wish to require that authors receive formal registration instruction and may need to monitor the submission process more closely.
The fact that authors do not always recognize their trials as RCTs and the apparent lack of trial registration has broad implications for identifying all the evidence for informing systematic reviews and healthcare decision making. If authors have no intention of publishing their findings and registration is not required by law [22] or a research ethics review board, or as a condition of funding by an agency such as the National Institutes of Health [23] , there is little incentive to register a trial. Community and commercial research ethics review boards in the US may not require registration [24] . Consistency in requiring trial registration through legislation, across funding and regulatory agencies, and research ethics boards, would likely increase registration and benefit the public and systematic reviewers alike.
Limitations
Our findings are limited to abstracts submitted to a single conference from 2004 through 2009 and may not apply to other years or areas of clinical research. The relatively low rate of correct identification of RCTs across the years searched implies that there is an ongoing problem with author classification of RCTs. Although we observed a high ''false positive'' rate for trial registration, this result may be due to the fact that registration is required for many types of ''clinical trials'' not just RCTs. We did not expect all abstracts with trial registration to be RCTs, but we did expect that all RCTs would be registered. We had hoped that a set of abstracts with trial registration would provide us an enriched and comprehensive source of RCTs to reduce the time and effort required to search the conference abstracts.
Implications
Our findings lead us to be somewhat pessimistic about authors being able to identify their own studies as randomized clinical trials. In addition, RCT investigators may not be registering their trials or reporting trial registration. Thus, it is unlikely that systematic reviewers would be able to use the author-classification of study design to identify ARVO abstracts describing RCTs.
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